8-K
Current Report
AXIM BIOTECHNOLOGIES, INC. Filed Acc 0001096906-22-000353
Material agreement · Agreement ended · New debt or obligation · Unregistered share sale
- Item 1.01 Entry into a material definitive agreement
- Item 1.02 Termination of a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
- Item 3.02 Unregistered sales of equity securities
From the SEC's structured data for this filing
Loading axim-20220210.htm…